StonvexLoading…
StonvexStonvexStonvexCore line items from HHS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $159.57M | $185.24M | $191.49M | $206.28M |
Operating Income | $386.00K | $2.09M | $3.36M | $15.11M |
Net Income | $-811.00K | $-30.30M | $-1.57M | $36.78M |
EPS (Diluted) | $-0.11 | $-4.15 | $-0.21 | $4.75 |
Total Assets | $91.83M | $101.78M | $122.76M | $119.98M |
Total Liabilities | $71.30M | $80.09M | $102.90M | $101.18M |
Cash & Equivalents | $5.58M | $9.81M | $18.36M | $10.36M |
Free Cash Flow OCF − CapEx | $-4.49M | $-6.73M | $7.67M | $22.99M |
Shares Outstanding | 7.41M | 7.36M | 7.22M | 7.40M |